Guro Løvik Goll

11PUBLICATIONS
38CO-AUTHORS
Other education not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityToxicology (incl. clinical toxicology)Medical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 07, 2025
Reply.

Elisabeth Gjefsen, John A Zwart, Lars C Bråten

|Dec 03, 2024
Efficacy of a Tumor Necrosis Factor Inhibitor in Chronic Low-Back Pain With Modic Type 1 Changes: A Randomized Controlled Trial.

Elisabeth Gjefsen, Lars C Bråten, Erica Ponzi

|Apr 10, 2024
Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study.

Hilde S Ørbo, Kristin H Bjørlykke, Joseph Sexton

|Nov 20, 2023
Therapeutic Drug Monitoring: A Tool to Optimize Treatment of Inflammatory Joint Diseases.

Silje W Syversen, Johanna E Gehin, Guro L Goll

|May 30, 2023
Cytokine Patterns as Predictors of Antibiotic Treatment Effect in Chronic Low Back Pain with Modic Changes: Subgroup Analyses of a Randomized Trial (AIM Study).

Lars Christian Haugli Bråten, Elisabeth Gjefsen, Kristina Gervin

|Feb 27, 2023
HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.

Marthe Kirkesaether Brun, Kristin Hammersbøen Bjørlykke, Marte K Viken

Pageof 2

Frequent Collaborators

7 joint publications

Silje Watterdal Syversen

4 joint publications

Tore K Kvien

3 joint publications

Elisabeth Gjefsen

3 joint publications

Sella Aarrestad Provan